AT284115B - Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen

Info

Publication number
AT284115B
AT284115B AT490869A AT490869A AT284115B AT 284115 B AT284115 B AT 284115B AT 490869 A AT490869 A AT 490869A AT 490869 A AT490869 A AT 490869A AT 284115 B AT284115 B AT 284115B
Authority
AT
Austria
Prior art keywords
arylhydrazinoimidazolinen
salts
preparation
new
Prior art date
Application number
AT490869A
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1966B0088361 external-priority patent/DE1670124B2/de
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of AT284115B publication Critical patent/AT284115B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT490869A 1966-08-05 1967-08-03 Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen AT284115B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1966B0088361 DE1670124B2 (de) 1966-08-05 1966-08-05 2-phenylhydrazino-imidazoline-(2), verfahren zu deren herstellung sowie diese enthaltende blutdrucksenkende zubereitungen
DEB0090823 1967-01-20

Publications (1)

Publication Number Publication Date
AT284115B true AT284115B (de) 1970-09-10

Family

ID=25968043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT490869A AT284115B (de) 1966-08-05 1967-08-03 Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen

Country Status (9)

Country Link
US (1) US3480630A (de)
AT (1) AT284115B (de)
CH (3) CH497432A (de)
DK (1) DK118607B (de)
FI (1) FI48082C (de)
FR (2) FR1550151A (de)
GB (1) GB1180794A (de)
IL (1) IL28433A (de)
YU (3) YU32176B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3516995A (en) * 1969-02-27 1970-06-23 Sandoz Ag Benzalhydrazones
DE2041734A1 (de) * 1970-08-22 1972-02-24 Bayer Ag Carbamate der 2-Phenylhydrazino-2-imidazoline,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasitizide
US4028380A (en) * 1974-06-01 1977-06-07 Akzona Incorporated Hydrazino-imidazole derivatives
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
US4117146A (en) * 1977-06-27 1978-09-26 The Dow Chemical Company Method for treating depression and anxiety using phenyl hydrazo compounds
JP2864075B2 (ja) * 1991-12-04 1999-03-03 富士写真フイルム株式会社 イミダゾールアゾ色素およびそれを含有する熱転写色素供与材料
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
EP2183216A1 (de) * 2007-07-27 2010-05-12 F. Hoffmann-Roche AG 2-azetidinmethynamine und 2-pyrrolidinmethanamine als taar-liganden
CN101784515A (zh) * 2007-08-03 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CR20180443A (es) 2016-03-17 2018-11-21 Hoffmann La Roche Derivado de morfolina

Also Published As

Publication number Publication date
FI48082C (fi) 1974-06-10
YU153867A (en) 1973-12-31
IL28433A (en) 1971-06-23
GB1180794A (en) 1970-02-11
YU32176B (en) 1974-06-30
FR1550151A (de) 1968-12-20
CH505111A (de) 1971-03-31
CH489502A (de) 1970-04-30
YU33864B (en) 1978-06-30
DK118607B (da) 1970-09-14
FI48082B (de) 1974-02-28
YU73377A (en) 1982-06-30
CH497432A (de) 1970-10-15
US3480630A (en) 1969-11-25
FR7322M (de) 1969-10-06
YU76573A (en) 1977-12-31

Similar Documents

Publication Publication Date Title
AT277223B (de) Verfahren zur Herstellung von neuen 2-Phenylimino-1-azacyclo-alkanen und ihren Salzen
AT278770B (de) Verfahren zur Herstellung von neuen N-substituierten Pyrrylaminoäthanolen und ihren Salzen
AT278024B (de) Verfahren zur Herstellung von neuen 3,1-Benzoxazin-Derivaten und ihren Salzen
AT267521B (de) Verfahren zur Herstellung von neuen 2-Halogen-benzimidazolen und ihren Salzen
AT277233B (de) Verfahren zur Herstellung von neuen N-(1-Alkyl-2-pyrrolidylmethyl)-3-alkoxy-indol-2-carboxamiden und ihren Salzen
AT284115B (de) Verfahren zur Herstellung von neuen 2-Arylhydrazinoimidazolinen-(2) und ihren Salzen
AT249025B (de) Verfahren zur Herstellung von neuen Dibenzocycloheptadienonoxim -O-äthern und ihren Salzen
AT273103B (de) Verfahren zur Herstellung von neuen 2-Phenylamino-2-oxazolinen und ihren Salzen
AT267515B (de) Verfahren zur Herstellung von neuen aminoalkylsubstituierten Phthalanen und ihren Salzen
AT281051B (de) Verfahren zur Herstellung von neuen Benzylsulfonyl-semicarbaziden und ihren Salzen
AT277269B (de) Verfahren zur Herstellung von neuen Benzotriazinonen und ihren Salzen
AT273107B (de) Verfahren zur Herstellung von neuen 2-Phenylamino-2-oxazolinen und ihren Salzen
AT273110B (de) Verfahren zur Herstellung von neuen 2-Phenylimino-oxazolidinen und ihren Salzen
AT295545B (de) Verfahren zur Herstellung von neuen 3-Aryl-benzazinen und ihren Salzen
AT280276B (de) Verfahren zur Herstellung von neuen 2-Arylhydrazino-imidazolinen-(2) und ihren Salzen
AT281809B (de) Verfahren zur Herstellung von neuen substituierten 3-Aminoacacylamino-thiophenen und ihren Salzen
AT286278B (de) Verfahren zur Herstellung von neuen 2-Phenylimino-pyrrolidinen und ihren Salzen
AT277279B (de) Verfahren zur Herstellung von neuen Guanidino-alkyl-azacycloalkanen und ihren Salzen
AT271473B (de) Verfahren zur Herstellung von neuen 2-Phenylamino-2-oxazolinen und ihren Salzen
AT287677B (de) Verfahren zur Herstellung von neuen 1-(3'-Hydroxy- bzw. -Acyloxy-5'-alkylphenyl)-2-aminoalkanolen und ihren Salzen
AT277276B (de) Verfahren zur Herstellung von neuen N'-substituierten N-Arylsulfonylharnstoffen und ihren Salzen
AT271492B (de) Verfahren zur Herstellung von neuen tertiären 1-Naphthylalkylaminen und ihren Salzen
AT276415B (de) Verfahren zur Herstellung von neuen 3,1-Benzothiazin-Derivaten und ihren Salzen
AT273981B (de) Verfahren zur Herstellung von neuen 1,2,8,9-Tetraazaphenalenen und ihren Salzen
AT263006B (de) Verfahren zur Herstellung von neuen 2-Oxaadamantan-1-aminen und ihren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee